Granules India Limited (532482) Earnings Call Transcripts

25 earnings calls from January 2020 to July 21, 2026

BSE IN Health Care Pharmaceuticals

About Granules India Limited

Granules India Limited (532482) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on BSE and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 25 calls on record spanning January 21, 2020 to July 21, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 25 Granules India Limited earnings call transcripts on record, spanning January 21, 2020 to July 21, 2026. Based on this history, Granules India Limited reports quarterly. The most recent call on file is dated July 21, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
532482
Exchange
BSE
Country
IN
Sector
Health Care
Industry
Pharmaceuticals
Calls on record
25
First call
January 21, 2020
Most recent
July 21, 2026
Reporting cadence
quarterly
Quarter Date
Q1 FY2027 Jul 21, 2026 Read transcript
Q4 FY2026 Apr 29, 2026 Read transcript
Q4 FY2025 May 28, 2025 Read transcript
Q3 FY2025 Jan 24, 2025 Read transcript
Q2 FY2025 Nov 6, 2024 Read transcript
Q1 FY2025 Jul 30, 2024 Read transcript
Q4 FY2024 May 15, 2024 Read transcript
Q3 FY2024 Jan 23, 2024 Read transcript
Q2 FY2024 Nov 9, 2023 Read transcript
Q1 FY2024 Aug 9, 2023 Read transcript
Q4 FY2023 May 16, 2023 Read transcript
Q3 FY2023 Jan 24, 2023 Read transcript
Q2 FY2023 Oct 20, 2022 Read transcript
Q1 FY2023 Aug 10, 2022 Read transcript
Q4 FY2022 May 19, 2022 Read transcript
Q3 FY2022 Feb 8, 2022 Read transcript
Q2 FY2022 Nov 13, 2021 Read transcript
Q1 FY2022 Jul 28, 2021 Read transcript
Q4 FY2021 May 11, 2021 Read transcript
Q3 FY2021 Jan 28, 2021 Read transcript
Q2 FY2021 Oct 20, 2020 Read transcript
Q1 FY2021 Jul 17, 2020 Read transcript
Q4 FY2020 Jun 2, 2020 Read transcript
Special Calls Mar 26, 2020 Read transcript
Q3 FY2020 Jan 21, 2020 Read transcript